Arena Pharma (ARNA) Reports Q3 Loss of $1.69/sh

Arena Pharma (NASDAQ: ARNA) reported Q3 EPS of ($1.69), versus ($1.46) reported last year. Revenue for the quarter came in at $20 thousand, versus $1.35 million reported last year.

For earnings history and earnings-related data on Arena Pharma (ARNA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Deutsche Bank monitors UK auto sales as Chinese exports grow
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand